Home
About Us
Covid-19
NRX-100/101
News
Contact
Home
News
Broadcasts
Prof Jonathan Javitt joins i24NEWS – FDA Grants Continuation of COVID-19 Trial
Prof Jonathan Javitt joins i24NEWS – FDA Grants Continuation of COVID-19 Trial
Broadcasts
June 15, 2020
August 5, 2020
Related Posts
News
August 5, 2020
August 6, 2020
Which COVID-19 treatments are showing promise? A list of potential drugs
Read more
News
August 2, 2020
August 6, 2020
Relief, NeuroRx say emergency treatment with RLF-100 helps critically ill Covid patients
Read more
Press releases
July 16, 2020
July 27, 2020
NeuroRx and Relief Therapeutics Announce Data Monitoring Committee Determination to Continue Phase 2/3 Trial of RLF-100 for Critical COVID-19
Read more
